Dr. Yana Najjar, MD
Claim this profileUPMC Hillman Cancer Center
Studies Skin Cancer
Studies Melanoma
12 reported clinical trials
16 drugs studied
Area of expertise
1Skin Cancer
Stage IV
BRAF positive
Stage III
2Melanoma
Stage IV
BRAF positive
Stage III
Affiliated Hospitals
Clinical Trials Yana Najjar, MD is currently running
Nivolumab
for Cancer
This phase Ib trial studies the side effects of nivolumab and to see how well it works in treating patients with autoimmune disorders and cancer that has spread to other places in the body or cannot removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Recruiting1 award Phase 120 criteria
VET3-TGI + Pembrolizumab
for Solid Tumors
VET3-TGI is an oncolytic immunotherapy designed to treat advanced cancers. VET3-TGI has not been given to human patients yet, and the current study is designed to find a safe and effective dose of VET3-TGI when administered by direct injection into tumor(s) (called an intratumoral injection) or when given intravenously (into the vein) both alone and in combination with pembrolizumab in patients with solid tumors (STEALTH-001).
Recruiting1 award Phase 13 criteria
More about Yana Najjar, MD
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Yana Najjar, MD has experience with
- Nivolumab
- Pembrolizumab
- Vusolimogene Oderparepvec (RP1)
- Axitinib
- Ribociclib
- Trametinib
Breakdown of trials Yana Najjar, MD has run
Skin Cancer
Melanoma
Uterine Tumors
Solid Tumors
Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yana Najjar, MD specialize in?
Yana Najjar, MD focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are BRAF positive.
Is Yana Najjar, MD currently recruiting for clinical trials?
Yes, Yana Najjar, MD is currently recruiting for 6 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Yana Najjar, MD has studied deeply?
Yes, Yana Najjar, MD has studied treatments such as Nivolumab, Pembrolizumab, Vusolimogene Oderparepvec (RP1).
What is the best way to schedule an appointment with Yana Najjar, MD?
Apply for one of the trials that Yana Najjar, MD is conducting.
What is the office address of Yana Najjar, MD?
The office of Yana Najjar, MD is located at: UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania 15213 United States. This is the address for their practice at the UPMC Hillman Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.